Salarius Pharmaceuticals, Inc. Common Stock
Symbol: SLRX (NASDAQ)
3.79
▲ (0.26%) 0.010
Company Description:
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.
Key Stats
- Today's Open: $3.83
- Today's High: $3.83
- Today's Low: $3.79
- Today's Volume: 58
- Yesterday Close: $3.78
- Yesterday High: $4.13
- Yesterday Low: $3.71
- Yesterday Volume: 272.41K
- Last Min Volume: 32
- Last Min High: $3.79
- Last Min Low: $3.79
- Last Min VWAP: $3.79
Company Profile
- Name: Salarius Pharmaceuticals, Inc. Common Stock
- Website: https://www.salariuspharma.com
- Listed Date: 2015-01-29
- Location: HOUSTON, TX
- Market Status: Active
- CIK Number: 0001615219
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $3.83M
- Round Lot: 100
- Outstanding Shares: 944.59K
- Asset Type: CS
RECENT FILINGS FOR SLRX
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-21 | S-1/A | View |
| 2025-10-21 | 8-K | View |
| 2025-10-14 | SCHEDULE 13G | View |
| 2025-10-14 | 8-K | View |
| 2025-10-06 | 8-K | View |
| 2025-09-26 | FWP | View |
| 2025-09-23 | S-1/A | View |
| 2025-09-18 | 8-K | View |
| 2025-09-09 | 8-K | View |
| 2025-08-27 | 8-K | View |
| 2025-08-26 | 8-K | View |
| 2025-08-26 | 8-K/A | View |
| 2025-08-22 | 424B5 | View |
| 2025-08-22 | 8-K | View |
| 2025-08-18 | 8-K | View |
| 2025-08-15 | S-3 | View |
| 2025-08-15 | 8-K | View |
| 2025-08-12 | 10-Q | View |
| 2025-08-08 | S-1/A | View |
| 2025-08-05 | FWP | View |
Latest News on SLRX